RVM
DGX icon

Robinson Value Management’s Quest Diagnostics DGX Stock Holding History

Robinson Value Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,873
Closed -$2.07M – 77
2022
Q3 		$2.07M Sell
16,873
-12,886
-43% -$1.7M 2.06% 17
2022
Q2 		$3.96M Sell
29,759
-117
-0.4% -$15.9K 3.67% 8
2022
Q1 		$4.09M Sell
29,876
-604
-2% -$84.2K 3.17% 8
2021
Q4 		$5.27M Buy
30,480
+12,491
+69% +$1.9M 4.33% 2
2021
Q3 		$2.61M Sell
17,989
-20
-0.1% -$2.93K 2.33% 17
2021
Q2 		$2.38M Sell
18,009
-109
-0.6% -$14.3K 1.94% 19
2021
Q1 		$2.33M Buy
+18,118
New +$2.23M 1.91% 19

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Robinson Value Management's DGX Position: Q4 2022 in Review

Robinson Value Management sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 16,873 shares — an estimated $2.07M sold.

Robinson Value Management first reported a position in DGX in Q1 2021 and held it in 7 quarters. The position peaked at $5.27M in Q4 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Robinson Value Management reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Robinson Value Management sold 16,873 Quest Diagnostics shares in Q4 2022, an estimated $2.07M.
  • Robinson Value Management first reported a position in Quest Diagnostics in Q1 2021 and held it in 7 quarters.
  • Robinson Value Management's Quest Diagnostics position peaked at $5.27M in Q4 2021.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Robinson Value Management's 13F filing for Q4 2022, filed 6 Feb 2023.